[1] Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249. [2] Chapman EJ,Edwards Z,Boland JW,et al.Practice review:Evidence-based and effective management of pain in patients with advanced cancer[J]. Palliat Med,2020,34(4):444-453. [3] 彭政,周莲清,王英,等.肿瘤患者镇痛药物素养评估问卷的编制及信效度检验[J].护理学杂志,2023,38(11):104-108. [4] Mercadante S.Cancer pain treatment strategies in patients with cancer[J]. Drugs,2022,82(13):1357-1366. [5] Mercadante S,Adile C,Tirelli W,et al.Barriers and adherence to pain management in advanced cancer patients[J]. Pain Pract,2021,21(4):388-393. [6] Liou KT,Trevino KM,Meghani SH,et al.Fear of analgesic side effects predicts preference for acupuncture:A cross-sectional study of cancer patients with pain in the USA[J]. Support Care Cancer,2021,29:427-435. [7] Yeager KA,Williams B,Bai J,et al.Factors related to adherence to opioids in black patients with cancer pain[J]. J Pain Symptom Manage,2019,57(1):28-36. [8] Vilardaga JCP,Fisher HM,Winger JG,et al.Pain,depressive symptoms,and self-efficacy for pain management:Examination in African-American women with breast cancer[J]. Support Care Cancer,2022,30(8):6633-6640. [9] 郝素娟,吴敏,杨菊英,等.老年癌痛病人疼痛信念与口服阿片类药物依从性的调查研究[J].护理研究,2019,33(22):3975-3978. [10] 周瑶群,方荣华.肿瘤患者癌性疼痛治疗依从性现状及其影响因素分析[J].华南预防医学,2022,48(4):412-415. [11] Zhao X,Xu R,Wang Y,et al.Adherence to analgesic drugs and its associated factors among patients with cancer pain:A cross-sectional study in China[J]. Am J Health Behav,2023,47(1):30-39. [12] Morisky DE,Green LW,Levine DM.Concurrent and predictive validity of a self-reported measure of medication adherence[J]. Med Care,1986:67-74. [13] 张斯钰,白丽琼,谭红专,等.Morisky服药依从性量表在肺结核患者中的应用[J].中国防痨杂志,2010,32(9):527-530. [14] Hjermstad MJ,Fayers PM,Haugen DF,et al.Studies comparing numerical rating scales,verbal rating scales,and visual analogue scales for assessment of pain intensity in adults:A systematic literature review[J]. J Pain Symptom Manage,2011,41(6):1073-1093. [15] Snaith RP.The hospital anxiety and depression scale[J]. Health Qual Life Outcomes,2003,1(1):1-4. [16] Yang Y,Ding R,Hu D,et al.Reliability and validity of a Chinese version of the HADS for screening depression and anxiety in psycho-cardiological outpatients[J]. Compr Psychiatry,2014,55(1):215-220. [17] 曹少宁,殷江敏,朱文娟,等.西安地区癌症患者慢性癌症相关性疼痛现状及影响因素分析[J].华南预防医学,2023,49(2):234-238. [18] Stapleton SJ,Dyal BW,Boyd AD,et al.Adherence to analgesics among outpatients seriously ill with cancer[J]. Cancer Nurs,2022,45(5):337-344. [19] Vanneste L,Lefebvre T,Tack L,et al.Pain medication adherence in patients with cancer:A pragmatic review[J]. Pain Med,2022,23(4):782-798. [20] Zhang C,Xiao J,Yu Z,et al.Cancer pain management and the roles of pharmacists in China[J]. Int J Clin Pharm,2021,43:383-385. [21] Xu X,Luckett T,Lovell M,et al.Cultural factors affecting Chinese migrants' perceptions and responses to cancer pain and its pharmacological management:A convergent mixed-method study[J]. Palliat Support Care,2022:1-9. [22] 张晓霞,罗倩,喻小艳,等.癌性疼痛影响因素与干预策略研究进展[J].护理研究,2022,36(15):2727-2731. [23] Scholz J,Finnerup NB,Attal N,et al.The IASP classification of chronic pain for ICD-11:Chronic neuropathic pain[J]. Pain,2019,160(1):53. [24] Fink RM,Gallagher E.Cancer pain assessment and measurement[J]. Semin Oncol Nurs,2019,35(3):229-234. [25] 李小梅,袁文茜,曹伯旭,等.慢性癌症相关性疼痛[J].中国疼痛医学杂志,2021,27(3):161-165. [26] Ludwick A,Corey K,Meghani S.Racial and socioeconomic factors associated with the use of complementary and alternative modalities for pain in cancer outpatients:An integrative review[J]. Pain Manage Nurs,2020,21(2):142-150. |